@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_head { this: np:hasAssertion dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_assertion; np:hasProvenance dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_provenance; np:hasPublicationInfo dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_publicationInfo; a np:Nanopublication . dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_assertion a np:Assertion . dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_provenance a np:Provenance . dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_publicationInfo a np:PublicationInfo . } dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_assertion { miriam-gene:5788 a ncit:C16612 . lld:C1961102 a ncit:C7057 . dgn-gda:DGNce01704d9f68beb017f0dd2e088140a4 sio:SIO_000628 miriam-gene:5788, lld:C1961102; a sio:SIO_001121 . } dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_provenance { dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_assertion dcterms:description "[Compared to CD45-low patients, CD45-high patients had a lower event-free survival rate (B-cell-precursor acute lymphoblastic leukemia: 72 ± 3% versus 86 ± 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 60 ± 8% versus 78 ± 4%, P=0.02), which was mainly attributable to a higher cumulative relapse incidence (B-cell-precursor acute lymphoblastic leukemia: 22 ± 3% versus 11 ± 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 31 ± 8% versus 11 ± 3%, P=0.003) and kept its significance in multivariate analysis considering sex, age, initial white blood cell count, and minimal residual disease in B-cell-precursor- and T-cell acute lymphoblastic leukemia, and additionally presence of ETV6/RUNX1, MLL/AF4 and BCR/ABL1 rearrangements in B-cell-precursor acute lymphoblastic leukemia (P=0.002 and P=0.025, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:23911702; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP1099163.RAmyFUM-NMMiqNTiUgQGNCYEaIebb236nvhdU_EffP7fI130_publicationInfo { this: dcterms:created "2016-05-13T12:50:04+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }